Overdiagnosis in randomised controlled trials of breast cancer screening

Breast Cancer Research

Volumn 7, Issue 5, 2005, Pages 230-234

  Moss, Sue ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BREAST CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CARCINOMA IN SITU; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; HUMAN; MAMMOGRAPHY; META ANALYSIS; REVIEW; ARTICLE; BREAST TUMOR; CONTROLLED CLINICAL TRIAL; MASS SCREENING; METHODOLOGY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; STANDARD;

BREAST NEOPLASMS; DIAGNOSTIC ERRORS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS;

EID: 25844501600     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr1314     Document Type: Review

References (18)

1. Yen MF, Tabar L, Vitak B, Smith RA, Chen HH, Duffy SW: Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening. Eur J Cancer 2003, 39:1746-1754.
2. Vainio H, Bianchini F: Breast Cancer Screening: IARC Handbooks of Cancer Prevention. Lyon: IARC Press; 2002.
3. Shapiro S, Venet W, Strax P, Venet L, Roeser R: Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982, 69:349-355.
4. Shapiro S: Evidence on screening for breast cancer from a randomized trial. Cancer 1977, 39:2772-2782.
5. Tabar L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Grontoft O, Ljunquist U, Lundstrom B, Manson JC, Eklund G, et al.: Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health & Welfare. Lancet 1985, i:829-832.
6. Duffy SW, Tabar L, Vitak B, Day NE, Smith RA, Chen HHT, Yen MFA: The relative contributions of screen-detected insitu and invasive breast carcinomas in reducing mortality from the disease. Eur J Cancer 2003, 39:1755-1760.
7. Bjurstam N, Bjorneld L, Warwick J, Sala E, Duffy SW, Nystrom L, Walker N, Cahlin E, Eriksson O, Hafstrom LO, et al.: The Gothenburg Breast Screening Trial. Cancer 2003, 97:2387-2396.
8. Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, Ljungberg O, Ranstam J, Sigfusson B: Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ 1988, 297:943-948.
9. Frisell J, Lidbrink E, Hellstrom L, Rutqvist L-E: Follow up after 11 years - update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat 1997, 45:263-270.
10. Miller AB, Baines CJ, To T, Wall C: Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. Can Med Assoc J 1992, 147:1477-1488.
11. Miller AB, To T, Baines CJ, Wall C: Canadian National Breast Screening Study - 2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 2000, 92:1490-1499.
12. Miller AB, Baines CJ, To T, Wall C: Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J 1992, 147:1459-1476.
13. Miller AB, To T, Baines CJ, Wall C: The Canadian National Breast Screening Study - 1: Breast cancer mortality after 11 to 16 years of follow-up. Ann Intern Med 2002, 137:E-305-E-315.
14. Alexander FE, Anderson TJ, Brown HK, Forrest AP, Hepburn W, Kirkpatrick AE, McDonald C, Muir BB, Prescott RJ, Shepherd SM: The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer 1994, 70:542-548.
15. Alexander FE, Anderson TJ, Brown HK, Forrest APM, Hepburn W, Kirkpatrick AE, Muir BB, Prescott RJ, Smith A: 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet 1999, 353:1903-1908.
16. Moss S: A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group. J Med Screen 1999, 6:144-148.
17. Moss S, Waller M, Anderson TJ, Cuckle H (writing committee for the Trial Management Group): Randomised controlled trial of mammographic screening in women from age 40: predicted mortality based on surrogate outcome measures. Br J Cancer 2005, 92:955-960.
18. The Breast Screening Frequency Trial Group: The frequency of breast cancer screening: results from the UKCCCR Randomised Trial. Eur J Cancer 2002, 38:1458-1464.